4/5
08:03 am
goss
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Low
Report
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
3/27
01:09 pm
goss
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $15.00 price target on the stock.
Low
Report
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $15.00 price target on the stock.
3/12
07:43 am
goss
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors [Yahoo! Finance]
Low
Report
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors [Yahoo! Finance]
3/12
07:31 am
goss
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
Low
Report
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
3/7
11:50 am
goss
Should You Buy Gossamer Bio (GOSS) After Golden Cross? [Yahoo! Finance]
Neutral
Report
Should You Buy Gossamer Bio (GOSS) After Golden Cross? [Yahoo! Finance]
3/6
11:58 am
goss
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Low
Report
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
3/6
11:58 am
goss
Gossamer Bio, Inc. (NASDAQ: GOSS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
Gossamer Bio, Inc. (NASDAQ: GOSS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $8.00. They now have a "buy" rating on the stock.
3/6
08:44 am
goss
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/5
07:44 am
goss
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/5
07:31 am
goss
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Medium
Report
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update